b 859 (Flecainide 50 mg)

Pill imprint b 859 has been identified as Flecainide acetate 50 mg.

Flecainide is used in the treatment of atrial fibrillation; atrial flutter; paroxysmal supraventricular tachycardia; supraventricular tachycardia; wolff-parkinson-white syndrome (and more), and belongs to the drug class group I antiarrhythmics. Risk cannot be ruled out during pregnancy. Flecainide 50 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for b 859

Flecainide acetate 50 mg b 859
Flecainide acetate
Imprint:
b
859
Strength:
50 mg
Color:
White
Size:
7.00 mm
Shape:
Round
Availability:
Prescription only
Drug Class:
Group I antiarrhythmics
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Teva Pharmaceuticals USA
National Drug Code (NDC):
00555-0859
Inactive Ingredients:
silicon dioxide
croscarmellose sodium
magnesium stearate
microcrystalline cellulose
corn starch
sodium stearyl fumarate

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web5)